# Allylescaline
*Source: https://psychonautwiki.org/wiki/Allylescaline*

## Dosage & Duration

### Oral

**Dosage:**
- Threshold: 15 mg
- Light: 20 - 30 mg
- Common: 30 - 40 mg
- Strong: 40 - 60 mg
- Heavy: 60 mg +

**Duration:**
- Total: 8 - 12 hours
- Onset: 45 - 240 minutes

**4-Allyloxy-3,5-dimethoxyphenethylamine** (also known as **allylescaline** ) is a lesser-known novel [psychedelic](https://psychonautwiki.org/wiki/Psychedelic) substance of the [phenethylamine](https://psychonautwiki.org/wiki/Phenethylamine) class. It is a structural analog of [mescaline](https://psychonautwiki.org/wiki/Mescaline) and related to [escaline](https://psychonautwiki.org/wiki/Escaline) and [methallylescaline](https://psychonautwiki.org/wiki/Methallylescaline) . It is relatively uncommon and has little to no history of human usage.

The effects of this compound were first described by [Alexander Shulgin](https://psychonautwiki.org/wiki/Alexander_Shulgin) in his book [PiHKAL](https://psychonautwiki.org/wiki/PiHKAL) : A Chemical Love Story. He lists the dosage range as 20 – 35 mg orally and describes the duration of action to be 8 - 12 hours.

[Subjective effects](https://psychonautwiki.org/wiki/Subjective_effects_index) bear appreciable similarity to [mescaline](https://psychonautwiki.org/wiki/Mescaline) and include [open and closed-eye visuals](https://psychonautwiki.org/wiki/Geometry) , [time distortion](https://psychonautwiki.org/wiki/Time_distortion) , [enhanced introspection](https://psychonautwiki.org/wiki/Introspection) , [conceptual thinking](https://psychonautwiki.org/wiki/Conceptual_thinking) , [euphoria](https://psychonautwiki.org/wiki/Euphoria) , and [ego loss](https://psychonautwiki.org/wiki/Ego_loss) . However, it is reported to produce comparatively less visual and cognitive effects when compared to mescaline or other closely related analogs.

Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline. It is highly advised to use [harm reduction practices](https://psychonautwiki.org/wiki/Harm_reduction_practices) if using this substance.

## Chemistry

Allylescaline, or 4-allyloxy-3,5-dimethoxyphenethylamine, is a substituted phenethylamine featuring a phenyl ring bound to an amino -NH2 group through an ethyl chain. Escaline contains two methoxy functional groups CH 3 O- which are attached to carbons R 3 , and R 5 and an additional allyloxy group at carbon R 4 of the phenyl ring. Allylescaline is the 4-allyloxy analog of [mescaline](https://psychonautwiki.org/wiki/Mescaline) .

Allylescaline, also referred to as 4-allyloxy-3,5-dimethoxyphenethylamine, is research compounds that is not well-known. The IUPAC name for Allylescaline is 4-Allyloxy-3,5-dimethoxyphenethylamine 4-Allyloxy-3,5-dimethoxy-1-ethylami with the molecular formula being C13H19NO3 and a molecular weight of 237.29 g/mol. Allylescaline is known to have an average mass of 237.294998 Da and a monoisotopic mass of 237.136002 Da.

## Pharmacology

Allylescaline acts as a [5-HT2A](https://psychonautwiki.org/wiki/Serotonin#The_5-HT_system) [partial agonist](https://psychonautwiki.org/wiki/Agonist#Agonists) . The [psychedelic](https://psychonautwiki.org/wiki/Psychedelic) effects are believed to come from allylescaline's efficacy at the 5-HT 2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

It is the 4O-allyl homolog of mescaline, and binds similarly to the serotonin receptors. It seems to have considerably increased potency by weight, with an active dose in humans reported to be 20-40 mg (compared to 300-400 mg for mescaline).

It is relatively uncommon and has little to no history of human usage. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline. The effects of this compound were first described by Alexander Shulgin in his book PiHKAL: A Chemical Love Story.

## Subjective effects

***Disclaimer:** The effects listed below cite the [Subjective Effect Index](https://psychonautwiki.org/wiki/Subjective_effect_index) ( **SEI** ), an open research literature based on anecdotal user reports and the personal analyses of [PsychonautWiki](https://psychonautwiki.org/wiki/PsychonautWiki) [contributors](https://psychonautwiki.org/wiki/Special:TopUsers) . As a result, they should be viewed with a healthy degree of skepticism.*

*It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. *Likewise, **adverse effects** become increasingly likely with higher doses and may include **addiction, severe injury, or death*** ☠.*
### Physical effects
 
- - **[Stimulation](https://psychonautwiki.org/wiki/Stimulation)** - In terms of its effects on the physical energy levels of the user, allylescaline is usually considered to be very energetic and stimulating without being forced. For example, when taken in any environment it will usually encourage physical activities such as running, walking, climbing or dancing. In comparison, other more commonly used psychedelics such as [psilocin](https://psychonautwiki.org/wiki/Psilocin) or [LSA](https://psychonautwiki.org/wiki/LSA) are generally sedating and relaxed.
- **[Spontaneous tactile sensations](https://psychonautwiki.org/wiki/Spontaneous_tactile_sensations)** - The "body high" of allylescaline can be characterized as proportionally very intense in comparison to its accompanying visual and cognitive effects. It is manifested in a number of forms including an intense soft, warm glow that grows over the body and is capable of becoming extremely physically euphoric. This is contrasted by a pleasant yet sharp electric sensation that moves up and down the body.
- **[Tactile enhancement](https://psychonautwiki.org/wiki/Tactile_enhancement)** - Allylescaline causes enhanced tactile sensations at all doses. Notably, allylescaline causes awareness of every sensation and every nerve ending in the body once level 8A geometry is reached. 
- **[Physical euphoria](https://psychonautwiki.org/wiki/Physical_euphoria)** - Relative to other psychedelics, allylescaline has been noted for the physically euphoric aspect that is vaguely reminiscent of other [phenethylamines](https://psychonautwiki.org/wiki/Phenethylamines) . In high or excessive dosages this effect can be diminished by uncomfortable physical side effects.
- **[Increased heart rate](https://psychonautwiki.org/wiki/Increased_heart_rate)**
- **[Increased libido](https://psychonautwiki.org/wiki/Increased_libido)** - When it occurs, this effect is mild to moderate
- **[Nausea](https://psychonautwiki.org/wiki/Nausea)** - Mild to extreme nausea is commonly reported and either passes instantly once the user has vomited or gradually fades by itself as the peak sets in.
- **[Pupil dilation](https://psychonautwiki.org/wiki/Pupil_dilation)**
- **[Muscle cramps](https://psychonautwiki.org/wiki/Muscle_cramps)**
- **[Muscle spasms](https://psychonautwiki.org/wiki/Muscle_spasms)** ### Visual effects
 
- #### Enhancements
 
- **[Colour enhancement](https://psychonautwiki.org/wiki/Colour_enhancement)**
- **[Pattern recognition enhancement](https://psychonautwiki.org/wiki/Pattern_recognition_enhancement)**
- **[Visual acuity enhancement](https://psychonautwiki.org/wiki/Visual_acuity_enhancement)**
 
#### Distortions
 
- **[Drifting](https://psychonautwiki.org/wiki/Drifting)** *( [melting](https://psychonautwiki.org/wiki/Drifting#Melting) , [breathing](https://psychonautwiki.org/wiki/Drifting#Breathing) , [morphing](https://psychonautwiki.org/wiki/Drifting#Morphing) and [flowing](https://psychonautwiki.org/wiki/Drifting#Flowing) )*
- **[Colour shifting](https://psychonautwiki.org/wiki/Colour_shifting)**
- **[Depth perception distortions](https://psychonautwiki.org/wiki/Depth_perception_distortions)**
- **[Perspective distortions](https://psychonautwiki.org/wiki/Perspective_distortions)**
- **[Symmetrical texture repetition](https://psychonautwiki.org/wiki/Symmetrical_texture_repetition)**
- **[Tracers](https://psychonautwiki.org/wiki/Tracers)**
- **[After images](https://psychonautwiki.org/wiki/After_images)**
- **[Brightness alteration](https://psychonautwiki.org/wiki/Brightness_alteration)**
- **[Diffraction](https://psychonautwiki.org/wiki/Diffraction)**
 
#### Geometry
 
#### Hallucinatory states
 
- **[Transformations](https://psychonautwiki.org/wiki/Transformations)**
- **[Internal hallucination](https://psychonautwiki.org/wiki/Internal_hallucination)** ( *[autonomous entities](https://psychonautwiki.org/wiki/Autonomous_entities)* ; *[settings, sceneries, and landscapes](https://psychonautwiki.org/wiki/Settings,_sceneries,_and_landscapes)* ; *[perspective hallucinations](https://psychonautwiki.org/wiki/Perspective_hallucinations)* and *[scenarios and plots](https://psychonautwiki.org/wiki/Scenarios_and_plots)* ) ### Cognitive effects
 
- - **[Conceptual thinking](https://psychonautwiki.org/wiki/Conceptual_thinking)**
- **[Cognitive euphoria](https://psychonautwiki.org/wiki/Cognitive_euphoria)**
- **[Delusion](https://psychonautwiki.org/wiki/Delusion)**
- **[Emotion enhancement](https://psychonautwiki.org/wiki/Emotion_enhancement)**
- **[Empathy, love, and sociability enhancement](https://psychonautwiki.org/wiki/Empathy,_love,_and_sociability_enhancement)**
- **[Immersion enhancement](https://psychonautwiki.org/wiki/Immersion_enhancement)**
- **[Increased music appreciation](https://psychonautwiki.org/wiki/Increased_music_appreciation)**
- **[Memory suppression](https://psychonautwiki.org/wiki/Memory_suppression)** 
- **[Ego death](https://psychonautwiki.org/wiki/Ego_death)**
- **[Novelty enhancement](https://psychonautwiki.org/wiki/Novelty_enhancement)**
- **[Personal bias suppression](https://psychonautwiki.org/wiki/Personal_bias_suppression)**
- **[Thought loops](https://psychonautwiki.org/wiki/Thought_loops)**
- **[Autonomous voice communication](https://psychonautwiki.org/wiki/Autonomous_voice_communication)**
- **[Time distortion](https://psychonautwiki.org/wiki/Time_distortion)**
- **[Unity and interconnectedness](https://psychonautwiki.org/wiki/Unity_and_interconnectedness)** ### Auditory effects
 
- - **[Enhancements](https://psychonautwiki.org/wiki/Auditory_enhancement)**
- **[Distortions](https://psychonautwiki.org/wiki/Auditory_distortion)**
- **[Hallucinations](https://psychonautwiki.org/wiki/Auditory_hallucinations)**
### Experience reports

There are currently 0 experience reports describing the effects of this substance in our [experience index](https://psychonautwiki.org/wiki/Experience_index) . You can also submit your own experience report using the same link.

Additional experience reports can be found here:

- [Erowid Experience Vaults: Allylescaline Reports](https://www.erowid.org/experiences/subs/exp_Allylescaline.shtml)

## Toxicity and harm potential

The toxicity and long-term health effects of recreational allylescaline use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because allylescaline is a [research chemical](https://psychonautwiki.org/wiki/Research_chemical) with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried allylescaline suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [Independent research](https://www.google.com/) should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use [harm reduction practices](https://psychonautwiki.org/wiki/Responsible_drug_use) when using this drug.

### Tolerance and addiction potential

Allylescaline is not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating.

Tolerance to the effects of allylescaline is built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). Allylescaline presents cross-tolerance with all [psychedelics](https://psychonautwiki.org/wiki/Psychedelic) , meaning that after the consumption of allylescaline all psychedelics will have a reduced effect.

## Legal issues

- **Germany** : Allylescaline is controlled under Anlage I BtMG ( *Narcotics Act, Schedule I* ) as of February 1, 1997 (called " *4-Allyloxy-3,5-dimethoxy-phenethylazan* "). It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
- **Japan** : Allylescaline is a controlled substance in Japan effective March 25th, 2015.
- **Sweden** : Allylescaline is illegal in Sweden as of January 2016.
- **Switzerland** : Allylescaline is a controlled substance specifically named under Verzeichnis E.
- **United Kingdom** : It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.

## See also

- [Responsible use](https://psychonautwiki.org/wiki/Responsible_use)
- [Mescaline](https://psychonautwiki.org/wiki/Mescaline)
- [Methallylescaline](https://psychonautwiki.org/wiki/Methallylescaline)
- [Proscaline](https://psychonautwiki.org/wiki/Proscaline)
- [Phenethylamine](https://psychonautwiki.org/wiki/Phenethylamine)
- [Hallucinogen](https://psychonautwiki.org/wiki/Hallucinogen)

## External links

- [Allylescaline (Wikipedia)](https://en.wikipedia.org/wiki/Allylescaline)
- [Allylescaline (PiHKAL / Isomer Design)](https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=2)

## References
1. ↑ [Shulgin, Alexander](https://psychonautwiki.org/wiki/Alexander_Shulgin); Shulgin, Ann (1991).["#2. AL"](https://erowid.org/library/books_online/pihkal/pihkal002.shtml).*[PiHKAL: A Chemical Love Story](https://psychonautwiki.org/wiki/PiHKAL)*. United States: Transform Press.[ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number)[0963009605](http://en.wikipedia.org/wiki/Special:BookSources/0963009605).[OCLC](http://en.wikipedia.org/wiki/OCLC)[1166889264](//www.worldcat.org/oclc/1166889264).
2. ↑ ["Gesetz über den Verkehr mit Betäubungsmitteln: Anlage I"](https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html)(in German). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
3. ↑ ["Neunte Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften"](http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl197s0065.pdf)(PDF).*Bundesgesetzblatt Jahrgang 1997 Teil I Nr. 5*(in German). Bundesanzeiger Verlag (published January 31, 1997). January 28, 1997. p. 65.[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0341-1095](//www.worldcat.org/issn/0341-1095).
4. ↑ ["Gesetz über den Verkehr mit Betäubungsmitteln: § 29"](https://www.gesetze-im-internet.de/btmg_1981/__29.html)(in German). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
5. ↑ ["危険ドラッグの成分１６物質を新たに指定薬物に指定"](https://www.mhlw.go.jp/stf/houdou/0000078803.html) (in Japanese). 厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]. Retrieved May 2, 2022.
6. ↑ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten
7. ↑ ["Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html)(in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
8. ↑ ["Psychoactive Substances Act 2016"](http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted). UK Government. Retrieved January 1, 2020.NewPP limit report Cached time: 20251218075200 Cache expiry: 1209600 Dynamic content: false Complications: [] [SMW] In‐text annotation parser time: 0.027 seconds CPU time usage: 0.213 seconds Real time usage: 0.409 seconds Preprocessor visited node count: 1153/1000000 Post‐expand include size: 80582/2097152 bytes Template argument size: 12639/2097152 bytes Highest expansion depth: 11/40 Expensive parser function count: 0/100 Unstrip recursion depth: 0/20 Unstrip post‐expand size: 7936/5000000 bytes Lua time usage: 0.140/7 seconds Lua virtual size: 7.74 MB/50 MB Lua estimated memory usage: 0 bytes ExtLoops count: 11Transclusion expansion time report (%,ms,calls,template) 100.00% 339.280 1 -total 26.79% 90.909 5 Template:Cite_web 22.23% 75.436 1 Template:Cite_book 18.06% 61.273 2 Template:Further 13.57% 46.056 1 Template:SubstanceBox/Allylescaline 12.22% 41.444 1 Template:SubstanceBox 7.28% 24.704 1 Template:Effects/base 6.39% 21.667 1 Template:Effect_list 5.45% 18.475 2 Template:Effect_column 4.99% 16.925 1 Template:Experience_reports